Why Are People Talking About Investing in DHR?

By Susan Ramirez • Saturday, December 02 15:12 • Permanent Link

More and more people are talking about Danaher over the last few weeks. Is it worth buying the Farm & Heavy Construction Machinery stock at a price of $223.48? Only time will tell. The information below will give you a basic idea of what this investment may entail:

Danaher has moved -18.0% over the last year, and the S&P 500 logged a change of 14.0%
DHR has an average analyst rating of buy and is 3.47% away from its mean target price of $215.98 per share
Its trailing earnings per share (EPS) is $7.93
Danaher has a trailing 12 month Price to Earnings (P/E) ratio of 28.2 while the S&P 500 average is 15.97
Its forward earnings per share (EPS) is $7.18 and its forward P/E ratio is 31.1
The company has a Price to Book (P/B) ratio of 3.15 in contrast to the S&P 500's average ratio of 2.95
Danaher is part of the Industrials sector, which has an average P/E ratio of 20.49 and an average P/B of 3.78
DHR has reported YOY quarterly earnings growth of -28.1% and gross profit margins of 0.6%
The company has a free cash flow of $5.2 Billion, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.